SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-010911
Filing Date
2021-05-05
Accepted
2021-05-05 16:30:31
Documents
3
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20210504_8k.htm 8-K 28590
2 EXHIBIT 99.1 ex_246611.htm EX-99.1 151022
3 dmac01.jpg GRAPHIC 4893
  Complete submission text file 0001437749-21-010911.txt   187696
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 21893853
SIC: 2834 Pharmaceutical Preparations